Sign Up to like & get
recommendations!
1
Published in 2022 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-21-1683
Abstract: SUMMARY CD19- and B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T cells have enabled unprecedented responses in a subset of refractory patients with B-cell and plasma cell malignancies, leading to their approval by the…
read more here.
Keywords:
cell therapies;
generation car;
next generation;
cell ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-nb2019-146
Abstract: A new model for studying T-cell exhaustion in human cells has enabled scientists to discover a transcription factor that, when overexpressed, helps make chimeric antigen receptor T cells resistant to this mechanism of immune failure.…
read more here.
Keywords:
cells counter;
generation car;
counter exhaustion;
next generation ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Blood"
DOI: 10.1182/blood.v130.suppl_1.3336.3336
Abstract: T.S. and I.J.G. contributed equally Background γδT cells mediate essential cancer immune surveillance by sensing transformation-dependent metabolic changes through their γδT cell receptors (TCRs). This process is independent ofMHC-restricted antigen presentation, making these innate-like receptors…
read more here.
Keywords:
generation car;
efficacy;
toxicity;
blood ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.907022
Abstract: Since chimeric antigen receptor (CAR) T-cell therapies for hematologic malignancies were approved by the U.S. Food and Drug Administration, numerous “next-generation” CAR T cells have been developed to improve their safety, efficacy, and applicability. Although…
read more here.
Keywords:
generation car;
car;
next generation;
car cells ... See more keywords